SCHEMBL1165503

SCHEMBL1165503

COC(=O)c1ccc(N)cc1C=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 6/20 0.62
ALDH1A1 P00352 8/20 0.49
KDM4E B2RXH2 5/20 0.49
MAPT P10636 4/20 0.49
HSD17B10 Q99714 3/20 0.49
HPGD P15428 3/20 0.49
GLA P06280 2/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49
ATM Q13315 1/20 0.49
ABL1 P00519 1/20 0.47
CFTR P13569 2/20 0.44
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA7 P43166 2/20 0.43
CA9 Q16790 2/20 0.43
CA14 Q9ULX7 2/20 0.43
PDK2 Q15119 1/20 0.43
PDK4 Q16654 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19511489 0.85 GAA (0.60) GAAALDH1A1KDM4EMAPTHSD17B10
SCHEMBL7293880 0.82 GAA (0.57) GAAALDH1A1KDM4EMAPTHSD17B10
SCHEMBL10082827 0.82 LMNA (0.51) GAAALDH1A1KDM4EMAPTHSD17B10
SCHEMBL7293894 0.82 GAA (0.57) GAAALDH1A1KDM4EMAPTHSD17B10
SCHEMBL24414556 0.81 CA12 (0.62) GAAALDH1A1KDM4EMAPTHSD17B10
SCHEMBL10844450 0.81 SLC6A4 (0.46) GAAALDH1A1KDM4EMAPTHSD17B10
SCHEMBL28984395 0.81 KDM4E (0.59) GAAALDH1A1KDM4EMAPTHSD17B10
SCHEMBL15265014 0.81 NR4A2 (0.47) GAAALDH1A1KDM4EMAPTHSD17B10
SCHEMBL30163539 0.80 MAPT (0.41) GAAALDH1A1KDM4EMAPTHSD17B10
SCHEMBL1403643 0.80 GAA (0.72) GAAALDH1A1KDM4EMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110039808-A1 Multitarget Compounds Active at a PPAR and Cannabinoid Receptor NOGRA PHARMA LIMITED (IE) 2011-02-17 US disclosed
EP-2222287-A2 MULTITARGET COMPOUNDS ACTIVE AT A PPAR AND CANNABINOID RECEPTOR Giuliani International Limited (IE) 2010-09-01 EP disclosed
WO-2009080821-A2 RECEPTOR TARGETING LIGANDS GIULIANI INTERNATIONAL LIMITED (IE) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039808-A1 Multitarget Compounds Active at a PPAR and Cannabinoid Receptor PPARA, PPARG, PPARD GAA 2026/4885ALDH1A1 899/4885KDM4E 1595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.